BJU Int
- UEKI H, Uemura M, Chinzei K, Takahashi K, et al 
 Developing an artificial intelligence model for phase recognition in 
robot-assisted radical prostatectomy.
 BJU Int. 2025;136:891-901.
 
 
- HANDA N, Shore ND, Cooperberg MR, Davicioni E, et al 
 Transcriptome profiling of prostatic tumours from ENACT trial patients with or 
without enzalutamide.
 BJU Int. 2025;136:920-929.
 
 
- CANNOLETTA D, Stabile A, Quarta L, Barletta F, et al 
 Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate 
Imaging-Reporting and Data System and biopsy history.
 BJU Int. 2025 Oct 13. doi: 10.1111/bju.70027.
 
 
 BMC Cancer
 
 
- YEBOAH KO, Atawuchugi P, Baah FK, Petershie BE, et al 
 The impact of zinc and testosterone co-treatment on tumourigenesis in prostate 
cancer: a novel model.
 BMC Cancer. 2025;25:1552.
 
 
 Br J Cancer
 
 
- ZUCKER K, McInerney C, Glaser A, Baxter P, et al 
 Why NHS hospital co-morbidity research may be wrong: how clinical coding fails to 
identify the impact of diabetes mellitus on cancer survival.
 Br J Cancer. 2025;133:1137-1144.
 
 
 Br J Radiol
 
 
- KURU OZ D, Yilmazer Zorlu SN, Eskalen Z, Haliloglu N, et al 
 Reevaluating prostate imaging-reporting and data system 3 lesions upgraded to 4: 
the emergence of a new subgroup?
 Br J Radiol. 2025;98:1683-1689.
 
 
- COOPER S, Chick J, Casey F, Alexander S, et al 
 Simulation-free radiotherapy on the MR-linac in prostate cancer.
 Br J Radiol. 2025;98:1591-1595.
 
 
 Cancer
 
 
-  
 Erratum to "Consensus-built recommendations to improve prostate cancer outcomes: 
A summary of the American Cancer Society Prostate Cancer Collaborative".
 Cancer. 2025;131:e70105.
 
 
 Clin Cancer Res
 
 
- BOUZAKI A, Vasquez Osorio E, Kerns S, van Herk M, et al 
 Integration of dose surface maps and genetic data identifies the lower posterior 
rectum as a key region for toxicity after prostate cancer radiotherapy.
 Clin Cancer Res. 2025 Oct 13. doi: 10.1158/1078-0432.CCR-25-2102.
 
 
- BRIGHI N, Wetterskog D, Vainauskas O, Orlando F, et al 
 Liquid biopsy identifies taxane resistance and clonal selection in 
castration-resistant prostate cancer.
 Clin Cancer Res. 2025 Oct 13. doi: 10.1158/1078-0432.CCR-25-2121.
 
 
 Eur Urol
 
 
- RIAZ IB, Cheng L, Montironi R 
 Histopathology-only Artificial Intelligence for Prostate Cancer: Towards 
Accessible Risk Stratification.
 Eur Urol. 2025 Oct 10:S0302-2838(25)04722-0. doi: 10.1016/j.eururo.2025.09.4164.
 
 
 Int J Cancer
 
 
- VLAMING M, Bleiker EMA, Schijven G, Kiemeney LALM, et al 
 Experiences of metastatic prostate cancer patients with a mainstream genetic 
testing pathway.
 Int J Cancer. 2025 Oct 13. doi: 10.1002/ijc.70194.
 
 
 Int J Radiat Oncol Biol Phys
 
 
- FITZPATRICK KJ, Mikell JK, Roseland ME, Niedbala J, et al 
 (177)Lu-PSMA-617 Single-Photon Emission Computed Tomography/Computed Tomography 
Dosimetry and Radiobiological Models Demonstrate Decreasing Tumor-to-Kidney Dose 
Ratio With Successive Cycles.
 Int J Radiat Oncol Biol Phys. 2025;123:937-946.
 
 
- DONG A, Sun X, Chen L, Tsai Y, et al 
 KDM3B Regulates Postradiation Fibrotic Responses in Prostate Stroma via 
N(6)-methyladenosine Modification of LOX.
 Int J Radiat Oncol Biol Phys. 2025;123:1116-1131.
 
 
- LUKKA HR, Pugh SL, Shipley WU, Major PP, et al 
 Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or 
Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation 
Therapy Postprostatectomy.
 Int J Radiat Oncol Biol Phys. 2025;123:990-999.
 
 
- SAYAN M, Miric G, Wallner KE, King MT, et al 
 Beyond the Beam: Redefining Survivorship in Prostate Cancer.
 Int J Radiat Oncol Biol Phys. 2025;123:1000-1003.
 
 
- NEILSEN BK, Huang RR, Valle LF, Proudfoot JA, et al 
 Genomic and Transcriptomic Profiling of Radiation-Resistant, Locally Recurrent 
Prostate Cancer.
 Int J Radiat Oncol Biol Phys. 2025 Sep 29:S0360-3016(25)06298.
 
 
 Int J Urol
 
 
- KAWAHARA T 
 Re: Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant 
Prostate Cancer in Japan: The ARASHI Study.
 Int J Urol. 2025 Oct 15. doi: 10.1111/iju.70259.
 
 
- ALANBUKI A 
 Editorial Comment: Prostate-Specific Antigen Dynamics and Bone Predominance as 
Predictors of Efficacy in Radium-223 Treatment for Castration-Resistant Prostate 
Cancer.
 Int J Urol. 2025 Oct 15. doi: 10.1111/iju.70264.
 
 
- YAJIMA S, Yoshida S, Fukushima H, Hirakawa A, et al 
 Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese 
Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Methodological 
Complement to Frequentist Analysis From the ARCHES Trial.
 Int J Urol. 2025 Oct 12. doi: 10.1111/iju.70256.
 
 
 J Clin Oncol
 
 
- LIN JK, Niu J, Giordano SH, Li P, et al 
 Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare 
Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and 
Prostate Cancers.
 J Clin Oncol. 2025;43:3254-3265.
 
 
 J Nucl Med
 
 
- MILLER SR, Chung DH, Gonzalez RT, Jackson WC, et al 
 Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate 
Cancer.
 J Nucl Med. 2025 Oct 16:jnumed.125.270825. doi: 10.2967/jnumed.125.270825.
 
 
 Magn Reson Imaging
 
 
- CHEN R, Hu G, Zhou B, Gan H, et al 
 Combination of clinicopathological and MRI based radiomics features in predicting 
homologous recombination repair genes mutations in prostate cancer.
 Magn Reson Imaging. 2025;124:110534.
 
 
 Nat Rev Urol
 
 
- RATNER D, Vassy JL 
 Clinical translation of polygenic scores for prostate cancer screening.
 Nat Rev Urol. 2025 Oct 13. doi: 10.1038/s41585-025-01095.
 
 
 PLoS One
 
 
- LI Y, Gillanders D, Finucane A 
 Experience of uncertainty in prostate cancer: A qualitative study.
 PLoS One. 2025;20:e0334180.
 
 
 Proc Natl Acad Sci U S A
 
 
- XIE J, Shen K, Liang W, Kuang Z, et al 
 Protein disulfide isomerases regulate androgen receptor stability and promote 
prostate cancer cell growth and survival.
 Proc Natl Acad Sci U S A. 2025;122:e2509222122.
 
 
 Urol Int
 
 
- RISCH J, Hugelmann K, Buck L, von Knobloch HC, et al 
 Readability of Prostate Cancer Patient Education Materials: A Comprehensive 
Assessment Using Readability Metrics.
 Urol Int. 2025 Oct 9:1-15. doi: 10.1159/000548884.
 
 
 
Free Medical Abstracts
 Privacy Policy
Privacy Policy
 Sponsors
Sponsors
 Share
Share
© Amedeo 1997-2016